Zoé van de Wyngaert

11PUBLICATIONS
20CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 18, 2025
NGS-based targeted sequencing guides risk-adapted and molecularly targeted therapy decisions in multiple myeloma.

Gaurav Agarwal, Mohammad Kazeroun, Mirian Salazar

|Oct 21, 2025
Debulking strategy prior to anti-BCMA/CD3 bispecific antibodies in extramedullary and/or high tumor burden RRMM: a retrospective cohort study.

Thomas Chalopin, Elise Cellerin, Hélène Demarquette

|May 31, 2024
Human herpesvirus type 6 reactivation after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide and antithymocyte globulin: risk factors and clinical impact.

Annalisa Paviglianiti, Tânia Maia, Joël-Meyer Gozlan

|May 31, 2024
Elranatamab treatment in a multiple myeloma patient undergoing renal dialysis.

Zoé Van de Wyngaert, Irene Romera-Martinez, Céline Chedeville

|Nov 26, 2021
Multiparameter flow cytometry in plasma cell disorders: when in doubt, go with the flow.

Zoé Van de Wyngaert, Eileen M Boyle

|Aug 11, 2021
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies.

Florent Malard, Béatrice Gaugler, Joel Gozlan

Pageof 2

Frequent Collaborators

4 joint publications

Mohamad Mohty

3 joint publications

Florent Malard

2 joint publications

Eileen M Boyle

2 joint publications

Rémy Dulery